Dr. Patrick Johannes Mansky, MD

Dr. Mansky practices at Frederick Health Hospital in Frederick, Maryland, part of Frederick Health.

Dr. Mansky's NPI, 1013931526, was assigned on July 27, 2006. Dr. Mansky holds Maryland license D0051559.

Dr. Mansky's primary practice is Frederick Health Hospital, at 400 West Seventh St, Frederick, MD 21701 in Frederick County. The practice phone is (240) 566-3300.

Dr. Mansky's primary practice is Frederick Health Hospital in Frederick, Maryland, part of Frederick Health. The medical group on file is Frederick Health Medical Group. Dmand AI also links Dr. Mansky to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mansky practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Mansky's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Mansky's licenses on file in 2 states: Maryland and Wisconsin.

CMS data shows 100,386 Medicare services from Dr. Mansky across 52 procedure codes in 2024, for 762 Medicare patients. Medicare paid $1,438,817 for them.

CMS counts 762 Medicare patients who saw Dr. Mansky in 2024. The largest group is 75 to 84, with 309 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mansky's median patient age at 57, with 77% women.

In 2024, Dr. Mansky wrote 734 Medicare Part D claims for 143 patients. 65% of them were for generic drugs. CMS names the drug for 568 of them, across 19 drugs with 11 or more claims each, at $940,095 in total drug cost. In 2023, CMS named 400 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Mansky for performance year 2024, reported as part of a group. Dr. Mansky accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mansky as offering telehealth.

Dmand AI links 2 papers to Dr. Mansky, published from 2013 to 2015. Dr. Mansky's most frequent co-authors are Harish Gangaram Ahuja, MD, Marc Roy Blackman, MD and Jules H. Blank, MD.

Dmand AI links Dr. Mansky to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Breast Neoplasms, Melanoma and Nevi and Melanomas. National Cancer Institute (NCI) sponsors the most, 6.

CMS Open Payments shows 163 general payments to Dr. Mansky from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Pfizer Inc. paid the most, $1,809.